Taiwan's Ministry of Economic Affairs (MOEA) has preliminarily found that low-priced polyamide film imports from China have materially injured domestic producers, potentially leading to anti-dumping duties. This development directly affects overseas buyers of medical aesthetics packaging, as polyamide film is widely used in sterile barrier packaging for injectables, skincare devices, and other medical-grade consumables. Importers and distributors should monitor the 70-day review period for temporary duties.
Market signal
Polyamide film, a high-performance polymer used in electronics, packaging, and automotive sectors, is also critical for medical aesthetics packaging—such as sterile pouches for syringes, needles, and implantable devices. Taiwan's MOEA reviewed data from January 2022 to March 2026, revealing that Chinese imports surged in volume while prices dropped continuously. Since 2025, import prices have fallen below domestic Taiwanese selling prices, triggering a price war that eroded local market share and caused losses for Taiwanese manufacturers.
Regulatory and channel signals
On June 9, 2026, the MOEA's Trade Relief Commission held a meeting and concluded there was reasonable indication of material injury to the domestic industry. The case has been forwarded to the Ministry of Finance, which has 70 days to decide whether to impose provisional anti-dumping duties. If duties are levied, they could raise the cost of Chinese polyamide film imports into Taiwan, affecting supply chains for medical aesthetics packaging that rely on this material.
Sourcing context
Polyamide film is a key material for high-barrier packaging in medical aesthetics, ensuring sterility and product integrity for injectables, dermal fillers, and aesthetic devices. Taiwanese manufacturers, who compete with Chinese suppliers, have struggled to maintain profitability. From 2023 to 2024, local producers cut prices to match Chinese imports, leading to expanded losses. By early 2026, they raised prices slightly and reduced costs, but remained unprofitable. This situation may prompt buyers to seek alternative sources or negotiate new terms.
What buyers should watch
Overseas importers and distributors of medical aesthetics packaging should track the Taiwan Ministry of Finance's decision within the next 70 days. If provisional anti-dumping duties are imposed, Chinese polyamide film prices in Taiwan could rise, potentially disrupting supply for Taiwanese OEMs that produce sterile packaging for global aesthetic brands. Buyers may consider diversifying suppliers or stockpiling inventory to mitigate short-term price volatility.
Source: Read the original report | Published: June 09, 2026